Therapeutics in Clinical Cardiovascular Practice. Experiences and Evidence

The quality of evidence in Cardiology has been intensified in the last years. By exceeding classic pharmachological and biological foundation, evidence-based methods of classic medicine, particu-larly randomized clinical assay, were applied to clinical scenario, allowing for discriminating among efficient, inert and injurious the-rapies. Classic studies, such as the one that demonstrated the inefficiency of mammary artery ligature surgery in the treatment of refractory chest angina, were predominantly carried out in car-diovascular diseases. The assimilation of methods of evidence-based medicine by corporations with corresponding investment in research and promotion, has expanded therapeutic and diagnostic possibilities quite much. However, it has been experienced a time of distortions in the relationship among corporations, academy and professionals, resulting from a strong corporate bias, which influences priorities of research, disclosure and prescription. Publi